Pepto Bismol Tablet, Chewable
NDC Package 58933-002-12
Package Information
Pepto Bismol (bismuth subsalicylate) tablets is • fully chew or dissolve in mouth before swallowing • adults and children 12 years and over: • 2 chewable tablets (1 dose) every 1/2 hour to 1 hour or 4 chewable tablets (2 doses) every hour as needed for diarrhea • 2 chewable tablets (1 dose) every 1/2 hour to 1 our as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)• do not exceed 8 doses (16 chewable tablets) in 24 hours• use until diarrhea stops but not more than 2 days• children under 12 years: ask a doctor• drink plenty of clear fluids to help prevent dehydration caused by diarrhea. This formulation utilizes a tablet, chewable delivery system. Marketed by Procter & Gamble Manufactura S De Rl De Cv, this product is identified by NDC 58933-002 and is authorized under FDA application M008.
Identification & Billing
- RxCUI: 211151 - Pepto-Bismol 262 MG Chewable Tablet
- RxCUI: 211151 - bismuth subsalicylate 262 MG Chewable Tablet [Pepto-bismol]
- RxCUI: 211151 - Pepto-bismol 262 MG Chewable Tablet
- RxCUI: 211151 - Pepto-Bismol InstaCool 262 MG Chewable Tablet
- RxCUI: 211151 - Pepto-Bismol To-Go 262 MG Chewable Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58933 - Procter & Gamble Manufactura S De Rl De Cv
- 58933-002 - Pepto Bismol
- 58933-002-12 - 6 CELLO PACK in 1 CARTON / 2 TABLET, CHEWABLE in 1 CELLO PACK
- 58933-002 - Pepto Bismol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58933-002-12 identifies a specific commercial package of 6 cello pack in 1 carton / 2 tablet, chewable in 1 cello pack of Pepto Bismol Chewables, a human over the counter drug labeled by Procter & Gamble Manufactura S De Rl De Cv. This tablet, chewable is formulated for oral use and contains bismuth subsalicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Procter & Gamble Manufactura S De Rl De Cv on April 01, 2025. The current certification is valid through December 31, 2027.
How is this Procter & Gamble Manufactura S De Rl De Cv product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58933000212. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.